ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

ViiV Healthcare 

Five Moore Drive

Research Triangle Park  North Carolina  27709-3398  U.S.A.
Phone: 877-844-8872 Fax: n/a


SEARCH JOBS








 Company News
ViiV Healthcare Expands Program To Reduce HIV Disparities In Southern U.S. 10/20/2014 8:47:30 AM
ViiV Healthcare Receives Approval For Triumeq™ (dolutegravir/abacavir/lamivudine), In Canada - A New Once-Daily Single-Pill Regimen For The Treatment Of HIV 10/14/2014 2:14:21 PM
GlaxoSmithKline (GSK)-Pfizer Inc. (PFE)'s ViiV Healthcare Wins Approval For HIV Combo Drug 8/22/2014 4:16:49 PM
ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3 7/22/2014 11:58:34 AM
GlaxoSmithKline (GSK)'s ViiV Healthcare Joins Johnson & Johnson (JNJ)'s Janssen Research & Development To Develop Single-Pill HIV Drug 6/12/2014 6:50:49 AM
GlaxoSmithKline (GSK)'s ViiV Healthcare Unit Adds New HIV Drug To AIDS Patent Pool 4/2/2014 7:33:44 AM
ViiV Healthcare Release: Tivicay® (dolutegravir) Receives Positive CHMP Opinion In Europe For The Treatment Of HIV 11/22/2013 10:29:30 AM
ViiV Healthcare Presents Positive Data From Phase 3b/4 Study of Dolutegravir Vs Darunavir in Treatment-Naive Adults With HIV-1 9/13/2013 7:12:44 AM
GlaxoSmithKline (GSK) Says No Plan for ViiV Healthcare Spinoff "at the Moment" 1/10/2013 7:33:50 AM
ViiV Healthcare Says Phase III Data From VIKING-3 Dolutegravir Study Encouraging 11/14/2012 7:19:13 AM
12